- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Zydus Lifesciences incorporates wholly owned subsidiary company in UAE
Ahmedabad: Zydus Lifesciences has incorporated a wholly owned subsidiary company in the name of Zydus Lifesciences Global FZE. in Jebel Ali Free Zone (“ZAFZA”), United Arab Emirates (“UAE”)."ZLGF having registration no. 74305372, is incorporated in ZAFZA, UAE on February 20, 2024 and is yet to commence its business operations," the Company stated in a BSE filing.Read also:...
Ahmedabad: Zydus Lifesciences has incorporated a wholly owned subsidiary company in the name of Zydus Lifesciences Global FZE. in Jebel Ali Free Zone (“ZAFZA”), United Arab Emirates (“UAE”).
"ZLGF having registration no. 74305372, is incorporated in ZAFZA, UAE on February 20, 2024 and is yet to commence its business operations," the Company stated in a BSE filing.
Read also: Zydus Lifesciences secures USFDA okay for angina drug Isosorbide Mononitrate ER
Medical Dialogues team had earlier reported that Zydus Lifesciences had reported a bigger-than-expected rise in third-quarter profit, driven by strong sales in its domestic and overseas markets.
Read also: Zydus Lifesciences reports bigger-than-expected rise in Q3 profit
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751